Discovery of novel ribosomally synthesized and post-translationally modified peptides (RiPPs) originating from unusual two-domain precursors

发现源自不寻常的双结构域前体的新型核糖体合成和翻译后修饰肽 (RiPP)

基本信息

项目摘要

Secondary metabolites (natural products) represent nature’s “chemical playground of evolution”, as these compounds show an exceptional structural diversity. Often, these metabolites have potent activities and many of them are harnessed for pharmaceutical applications. The identification of novel secondary metabolites and the characterization of the corresponding biosynthetic enzymes are thus of great importance to understand the genetic and biochemical mechanisms that evolved this great chemical diversity. Further, the discovery of novel compounds with biological activities enables the development of new anti-infectives, which are urgently needed in light of increased antibiotic resistance. This project focuses on a unique group of ribosomally synthesized and post-translationally modified peptides (RiPPs) from bacteria. RiPPs are a large class of secondary metabolites that are derived from genetically encoded precursor peptides that undergo post-translation modification. The precursor peptides usually consist of a leader sequence and a core sequence. Different enzymes recognize the leader and install post-translational modifications on the core peptide, which is released as the mature natural product after proteolytic cleavage. Leader sequences are often short and lack clear structural features. As an exception, the family of the “nitrile hydratase leader peptides” (NHLP) are characterized by unusually long leader sequences that show similarity to the enzyme nitrile hydratase. In certain species of the order Burkholderiales, these NHLP precursors further appear as tandem genes, i.e., two copies of the precursor are present in a row. Intriguingly, in a few strains, these genes are fused into a single two-domain precursor, resulting in a large ~270 amino acid precursor protein. The function of the two leader domains, as well as the nature of the resulting RiPPs is currently unclear. The unique domain architecture of these precursors likely affects the maturation of the resulting peptides and represents an unexplored and exciting opportunity for the discovery of RiPPs with novel structures and functions. In this project, we aim to investigate these so-far uncharacterized RiPP gene clusters to identify the produced metabolite(s), characterize the biosynthetic enzymes, and explore the role of the two leader domains in the precursors. We will employ top-down approaches, including metabolomics and proteomics, in order to identify and isolate the RiPPs from the producing organisms. We will further complement these methods with a bottom-up approach where we will iteratively reconstitute the biosynthetic genes in Escherichia coli to monitor the successive installment of modifications in the precursor. To understand the function of the two NHLP domains in the precursor, we plan to crystallize the protein and solve its structure. Lastly, isolated RiPPs will be assessed for their bioactivities to evaluate their anti-infective potential.
次级代谢产物(天然产物)代表了自然界的“进化的化学游乐场”,因为这些化合物显示出特殊的结构多样性。通常,这些代谢物具有有效的活性,其中许多被用于制药应用。因此,新的次级代谢产物的鉴定和相应的生物合成酶的表征对于理解进化这种巨大化学多样性的遗传和生化机制具有重要意义。此外,具有生物活性的新型化合物的发现使得能够开发新的抗感染药,鉴于抗生素耐药性的增加,迫切需要这种抗感染药。该项目的重点是一组独特的核糖体合成和后修饰的肽(RIPPs)从细菌。RiPP是一大类次级代谢产物,其衍生自经历翻译后修饰的遗传编码的前体肽。前体肽通常由前导序列和核心序列组成。不同的酶识别前导序列并在核心肽上进行翻译后修饰,核心肽在蛋白水解切割后作为成熟的天然产物释放。前导序列通常很短,缺乏明确的结构特征。作为例外,“腈水合酶前导肽”(NHLP)家族的特征在于显示出与腈水合酶相似性的异常长的前导序列。在伯克霍尔德菌目的某些物种中,这些NHLP前体进一步表现为串联基因,即,前体的两个拷贝存在于一行中。有趣的是,在一些菌株中,这些基因融合成一个单一的双结构域前体,产生一个大的~270个氨基酸的前体蛋白。这两个前导结构域的功能以及所产生的RIPP的性质目前尚不清楚。这些前体的独特结构域结构可能影响所得肽的成熟,并代表了发现具有新结构和功能的RIPP的未开发和令人兴奋的机会。在这个项目中,我们的目标是研究这些迄今尚未表征的RiPP基因簇,以确定产生的代谢产物,表征生物合成酶,并探索两个前导结构域在前体中的作用。我们将采用自上而下的方法,包括代谢组学和蛋白质组学,以确定和分离的RIPPs从生产生物体。我们将进一步补充这些方法与自下而上的方法,我们将迭代重建大肠杆菌中的生物合成基因,以监测前体中修饰的连续分期付款。为了了解前体中两个NHLP结构域的功能,我们计划将蛋白质结晶并解析其结构。最后,将评估分离的RIPP的生物活性,以评价其抗感染潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Gerald Lackner其他文献

Professor Dr. Gerald Lackner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Gerald Lackner', 18)}}的其他基金

Future directions in cofactor research: Discovery and development of coenzyme F420-dependent bioprocesses
辅因子研究的未来方向:辅酶 F420 依赖性生物过程的发现和开发
  • 批准号:
    408113938
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
  • 批准号:
    82070530
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
  • 批准号:
    32002421
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
  • 批准号:
    31902347
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Understanding The Political Representation of Men: A Novel Approach to Making Politics More Inclusive
了解男性的政治代表性:使政治更具包容性的新方法
  • 批准号:
    EP/Z000246/1
  • 财政年份:
    2025
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Automating a novel multi-tool additive and subtractive manufacturing platform for micrometre-resolution prototyping across diverse industries
自动化新型多工具增材和减材制造平台,用于跨不同行业的微米分辨率原型制作
  • 批准号:
    10097846
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Powering Small Craft with a Novel Ammonia Engine
用新型氨发动机为小型船只提供动力
  • 批准号:
    10099896
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
NEM-EMERGE: An integrated set of novel approaches to counter the emergence and proliferation of invasive and virulent soil-borne nematodes
NEM-EMERGE:一套综合的新方法来对抗入侵性和剧毒土传线虫的出现和扩散
  • 批准号:
    10080598
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Mathematics to underpin and drive novel inertial microfluidic technologies
数学支撑和驱动新型惯性微流体技术
  • 批准号:
    DP240101089
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
A Novel Surrogate Framework for evaluating THM Properties of Bentonite
评估膨润土 THM 性能的新型替代框架
  • 批准号:
    DP240102053
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
EFR3: Novel gatekeeper of cell proliferation
EFR3:细胞增殖的新型看门人
  • 批准号:
    DP240102729
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Proof of alcoholic beverage consumption based on the quantitation of novel biomarkers
基于新型生物标志物定量的酒精饮料消费证明
  • 批准号:
    24K13564
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel chelators for Scandium-44 in PET imaging of prostate cancer
用于前列腺癌 PET 成像的新型 Scandium-44 螯合剂
  • 批准号:
    2904564
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
Novel Ceramic Coatings for High Temperature Applications
适用于高温应用的新型陶瓷涂层
  • 批准号:
    2905977
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了